Aloetherapeutics
2 known investors
Find your way into Aloetherapeutics
Sign up to see every warm intro you have to Aloetherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aloetherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Aloe Therapeutics develops AIM-001, a localized cell-based immunotherapy implanted at tumor sites during surgery to activate the immune system and improve response to checkpoint immunotherapy in patients with advanced solid tumors.
Investors · 2
Frequently asked questions
- What does Aloetherapeutics do?
- Aloe Therapeutics develops AIM-001, a localized cell-based immunotherapy implanted at tumor sites during surgery to activate the immune system and improve response to checkpoint immunotherapy in patients with advanced solid tumors.
- Who are Aloetherapeutics's investors?
- Aloetherapeutics's investors include Maryland TEDCO, TEDCO.